Chambers, J. E., Zubkov, N., Kubánková, M., Nixon-Abell, J., Mela, I., Abreu, S., Schwiening, M., Lavarda, G., López-Duarte, I., Dickens, J. A., Torres, T., Kaminski, C., Holt, L., Avezov, E., Huntington, J., George-Hyslop, P., Kuimova, M., & Marciniak, S. (2022). Z-α1-antitrypsin polymers impose molecular filtration in the endoplasmic reticulum after undergoing phase transition to a solid state. Science Advances, 8. DOI:10.1126/sciadv.abm2094

​

Dasari, A. K. R., Hung, I., Michael, B., Gan, Z., Kelly, J., Connors, L., Griffin, R., & Lim, K. (2020). Structural characterization of cardiac ex vivo transthyretin amyloid: Insight into transthyretin misfolding pathway in vivo. Biochemistry. DOI: 10.1021/acs.biochem.0c00091

​

Jagger, A., Waudby, C., Irving, J., Christodoulou, J., & Lomas, D. (2020). High-resolution ex vivo NMR spectroscopy of human Z α1-antitrypsin. Nature Communications, 11. https://doi.org/10.1038/s41467-020-20147-7

​

Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Zídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596, 583–589. https://doi.org/10.1038/s41586-021-03819-2

​

Liddle, J., Pearce, A., Arico-Muendel, C., Belyanskaya, S., Brewster, A., Brown, M. J. B., Chung, C., Denis, A., Dodic, N., Dossang, A., Eddershaw, P., Klimaszewska, D., Haq, I., Holmes, D., Jagger, A., Jakhria, T., Jigorel, E., Lind, K., Messer, J. A., … Lomas, D. (2021). The development of highly potent and selective small molecule correctors of Z α1-antitrypsin misfolding. Bioorganic & Medicinal Chemistry Letters, 127973. https://doi.org/10.1016/j.bmcl.2021.127973

​

Roberts, B. S., Mitra, D., Abishek, S., Beher, R., & Satpute-Krishnan, P. (2024). The p24-family and COPII subunit SEC24C facilitate the clearance of alpha1-antitrypsin Z from the endoplasmic reticulum to lysosomes. Molecular Biology of the Cell, 35. https://doi.org/10.1091/mbc.E23-06-0257

​

Strnad, P., & San Martin, J. (2023). RNAi therapeutics for diseases involving protein aggregation: Fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease. Expert Opinion on Investigational Drugs, 32, 571–581. https://doi.org/10.1080/13543784.2023.2239707

​

Wagner, W. J., & Gross, M. L. (2022). Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta. Mass Spectrometry Reviews. https://doi.org/10.1002/mas.21814

​

Wojciechowska, A. W., Wojciechowski, J. W., & Kotulska, M. (2024). Non-standard proteins in the lenses of AlphaFold3 - Case study of amyloids. bioRxiv. https://doi.org/10.1101/2024.07.09.602655